We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Sempra
SRE
$60.8B
| $215K | ﹤0.01% |
3,250
| – | – |
|
977
Alaska Air
ALK
$5.15B
| $214K | ﹤0.01% |
3,550
-1,006
| -22% | -$67.9K |
|
|
CCRN
978
DELISTED
Cross Country Healthcare
CCRN
| $214K | ﹤0.01% |
12,935
-149,651
| -92% | -$2.28M |
|
979
Wave Life Sciences
WVE
$1.12B
| $212K | ﹤0.01% |
31,896
-68,478
| -68% | -$447K |
|
980
FNB Corp
FNB
$6.78B
| $210K | ﹤0.01% |
+17,055
| New | +$222K |
|
|
XXII
981
22nd Century Group
XXII
$1.47M
| – | – |
0
| – | – |
|
|
CLDT
982
Chatham Lodging
CLDT
$630M
| $208K | ﹤0.01% |
16,126
-399
| -2% | -$5.32K |
|
983
UroGen Pharma
URGN
$2B
| $207K | ﹤0.01% |
+13,548
| New | +$245K |
|
984
CSX Corp
CSX
$98.6B
| $206K | ﹤0.01% |
6,426
| – | – |
|
985
Energy Recovery
ERII
$434M
| $206K | ﹤0.01% |
9,024
-13,749
| -60% | -$271K |
|
|
CMRX
986
DELISTED
Chimerix, Inc.
CMRX
| $205K | ﹤0.01% |
25,681
+1,467
| +6% | +$12.2K |
|
987
F5
FFIV
$22.1B
| $201K | ﹤0.01% |
1,075
| – | – |
|
|
TESS
988
DELISTED
Tessco Technologies Inc
TESS
| $201K | ﹤0.01% |
32,618
+2,400
| +8% | +$17.6K |
|
|
ATCX
989
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $201K | ﹤0.01% |
+20,745
| New | +$219K |
|
990
Vitamin Cottage Natural Grocers
NGVC
$691M
| $197K | ﹤0.01% |
+18,308
| New | +$248K |
|
991
Horizon Bancorp
HBNC
$1.03B
| $195K | ﹤0.01% |
+11,195
| New | +$204K |
|
992
Western New England Bancorp
WNEB
$287M
| $191K | ﹤0.01% |
23,468
+6,995
| +42% | +$57.8K |
|
|
KIN
993
DELISTED
Kindred Biosciences, Inc.
KIN
| $191K | ﹤0.01% |
20,777
-300,263
| -94% | -$1.75M |
|
994
Rimini Street
RMNI
$408M
| $185K | ﹤0.01% |
30,052
-724
| -2% | -$5.29K |
|
|
VEI
995
DELISTED
Vine Energy Inc.
VEI
| $183K | ﹤0.01% |
+11,765
| New | +$162K |
|
996
OP Bancorp
OPBK
$233M
| $182K | ﹤0.01% |
18,134
| – | – |
|
997
Riverview Bancorp
RVSB
$107M
| $167K | ﹤0.01% |
23,506
| – | – |
|
|
IVAC
998
DELISTED
Intevac Inc
IVAC
| $160K | ﹤0.01% |
23,670
-120,745
| -84% | -$785K |
|
999
Mustang Bio
MBIO
$4.26M
| $157K | ﹤0.01% |
63
-1,305
| -95% | -$3.2M |
|
1000
Precision BioSciences
DTIL
$188M
| $156K | ﹤0.01% |
414
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.